News for Healthier Living

Pivotal SPRAY-CB Trial of RejuvenAir(r) Published in American Journal of Respiratory and Critical Care Medicine

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the publication in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) of results from SPRAY-CB (NCT03893370), the pivotal randomized, blinded, sham-controlled trial evaluating Metered CryoSpray(tm) (MCS) therapy with the RejuvenAir(r) System in patients with moderate-to-severe COPD and symptomatic chronic bronchitis.

September 23, 2026


October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026